|
Volumn 96, Issue 2, 2010, Pages 124-132
|
Total hip arthroplasty revision due to infection: A cost analysis approach
|
Author keywords
Cost analysis; Mechanical loosening; Revision due to infection; Total hip arthroplasty
|
Indexed keywords
AMOXICILLIN;
CEFALEXIN;
CIPROFLOXACIN;
CLINDAMYCIN;
DALACINE;
FUSIDATE SODIUM;
MINOCYCLINE;
PEFLOXACIN;
RIFAMPICIN;
UNCLASSIFIED DRUG;
ANTIBIOTIC THERAPY;
ARTICLE;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DRUG COST;
HEALTH CARE COST;
HEALTH INSURANCE;
HOME CARE;
HOSPITALIZATION COST;
HUMAN;
LENGTH OF STAY;
PREOPERATIVE EVALUATION;
PRIORITY JOURNAL;
PROSTHESIS INFECTION;
REHABILITATION CARE;
TOTAL HIP PROSTHESIS;
ARTHROPLASTY, REPLACEMENT, HIP;
COSTS AND COST ANALYSIS;
FRANCE;
HEALTH CARE COSTS;
HUMANS;
LENGTH OF STAY;
PROSTHESIS-RELATED INFECTIONS;
REOPERATION;
RETROSPECTIVE STUDIES;
|
EID: 77952105469
PISSN: 18770568
EISSN: None
Source Type: Journal
DOI: 10.1016/j.otsr.2009.11.004 Document Type: Article |
Times cited : (216)
|
References (7)
|